 | • レポートコード：MRC2102QY7404 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のインターロイキン17A市場について種類別（ABY-035、CNTO-6785、DLX-2882、その他）、用途別（慢性疼痛、肝臓がん、腎臓がん、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・インターロイキン17A市場の概要 ・世界の主要地域別インターロイキン17A市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のインターロイキン17A市場規模2015-2026：種類別（ABY-035、CNTO-6785、DLX-2882、その他） ・世界のインターロイキン17A市場規模2015-2026：用途別（慢性疼痛、肝臓がん、腎臓がん、その他） ・インターロイキン17Aの米国市場規模2015-2020 ・インターロイキン17Aのヨーロッパ市場規模2015-2020 ・インターロイキン17Aの中国市場規模2015-2020 ・インターロイキン17Aの日本市場規模2015-2020 ・インターロイキン17Aの東南アジア市場規模2015-2020 ・インターロイキン17Aのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・インターロイキン17Aの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インターロイキン17Aの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Interleukin 17A Market
The global Interleukin 17A market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Interleukin 17A Scope and Market Size
The global Interleukin 17A market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Interleukin 17A market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Interleukin 17A market is segmented into
ABY-035
CNTO-6785
DLX-2882
Others
Segment by Application, the Interleukin 17A market is segmented into
Chronic Pain
Liver Cancer
Kidney Cancer
Others
The Interleukin 17A market is analysed and market size information is provided by regions (countries). Segment by Application, the Interleukin 17A market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Interleukin 17A Market Share Analysis
Interleukin 17A market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Interleukin 17A business, the date to enter into the Interleukin 17A market, Interleukin 17A product introduction, recent developments, etc.
The major vendors covered:
AbbVie Inc
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis AG
Orega Biotech SAS
1 Interleukin 17A Market Overview
1.1 Interleukin 17A Product Scope
1.2 Interleukin 17A Segment by Type
1.2.1 Global Interleukin 17A Sales by Type (2020-2026)
1.2.2 ABY-035
1.2.3 CNTO-6785
1.2.4 DLX-2882
1.2.5 Others
1.3 Interleukin 17A Segment by Application
1.3.1 Global Interleukin 17A Sales Comparison by Application (2020-2026)
1.3.2 Chronic Pain
1.3.3 Liver Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Interleukin 17A Market Estimates and Forecasts (2015-2026)
1.4.1 Global Interleukin 17A Sales Growth Rate (2015-2026)
1.4.2 Global Interleukin 17A Revenue and Growth Rate (2015-2026)
1.4.3 Global Interleukin 17A Price Trends (2015-2026)
2 Interleukin 17A Estimate and Forecast by Region
2.1 Global Interleukin 17A Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Interleukin 17A Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Interleukin 17A Sales Market Share by Region (2015-2020)
2.2.2 Global Interleukin 17A Revenue Market Share by Region (2015-2020)
2.3 Global Interleukin 17A Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Interleukin 17A Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Interleukin 17A Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Interleukin 17A Estimates and Projections (2015-2026)
2.4.2 Europe Interleukin 17A Estimates and Projections (2015-2026)
2.4.3 China Interleukin 17A Estimates and Projections (2015-2026)
2.4.4 Japan Interleukin 17A Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Interleukin 17A Estimates and Projections (2015-2026)
2.4.6 India Interleukin 17A Estimates and Projections (2015-2026)
3 Global Interleukin 17A Competition Landscape by Players
3.1 Global Top Interleukin 17A Players by Sales (2015-2020)
3.2 Global Top Interleukin 17A Players by Revenue (2015-2020)
3.3 Global Interleukin 17A Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interleukin 17A as of 2019)
3.4 Global Interleukin 17A Average Price by Company (2015-2020)
3.5 Manufacturers Interleukin 17A Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Interleukin 17A Players (Opinion Leaders)
4 Global Interleukin 17A Market Size by Type
4.1 Global Interleukin 17A Historic Market Review by Type (2015-2020)
4.1.1 Global Interleukin 17A Sales Market Share by Type (2015-2020)
4.1.2 Global Interleukin 17A Revenue Market Share by Type (2015-2020)
4.1.3 Global Interleukin 17A Price by Type (2015-2020)
4.2 Global Interleukin 17A Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Interleukin 17A Sales Forecast by Type (2021-2026)
4.2.2 Global Interleukin 17A Revenue Forecast by Type (2021-2026)
4.2.3 Global Interleukin 17A Price Forecast by Type (2021-2026)
5 Global Interleukin 17A Market Size by Application
5.1 Global Interleukin 17A Historic Market Review by Application (2015-2020)
5.1.1 Global Interleukin 17A Sales Market Share by Application (2015-2020)
5.1.2 Global Interleukin 17A Revenue Market Share by Application (2015-2020)
5.1.3 Global Interleukin 17A Price by Application (2015-2020)
5.2 Global Interleukin 17A Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Interleukin 17A Sales Forecast by Application (2021-2026)
5.2.2 Global Interleukin 17A Revenue Forecast by Application (2021-2026)
5.2.3 Global Interleukin 17A Price Forecast by Application (2021-2026)
6 United States Interleukin 17A Market Facts & Figures
6.1 United States Interleukin 17A Sales Market Share by Company (2015-2020)
6.2 United States Interleukin 17A Sales Market Share by Type (2015-2020)
6.3 United States Interleukin 17A Sales Market Share by Application (2015-2020)
7 Europe Interleukin 17A Market Facts & Figures
7.1 Europe Interleukin 17A Sales Market Share by Company (2015-2020)
7.2 Europe Interleukin 17A Sales Market Share by Type (2015-2020)
7.3 Europe Interleukin 17A Sales Market Share by Application (2015-2020)
8 China Interleukin 17A Market Facts & Figures
8.1 China Interleukin 17A Sales Market Share by Company (2015-2020)
8.2 China Interleukin 17A Sales Market Share by Type (2015-2020)
8.3 China Interleukin 17A Sales Market Share by Application (2015-2020)
9 Japan Interleukin 17A Market Facts & Figures
9.1 Japan Interleukin 17A Sales Market Share by Company (3015-3030)
9.2 Japan Interleukin 17A Sales Market Share by Type (2015-2020)
9.3 Japan Interleukin 17A Sales Market Share by Application (2015-2020)
10 Southeast Asia Interleukin 17A Market Facts & Figures
10.1 Southeast Asia Interleukin 17A Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Interleukin 17A Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Interleukin 17A Sales Market Share by Application (2015-2020)
11 India Interleukin 17A Market Facts & Figures
11.1 India Interleukin 17A Sales Market Share by Company (2015-2020)
11.2 India Interleukin 17A Sales Market Share by Type (2015-2020)
11.3 India Interleukin 17A Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Interleukin 17A Business
12.1 AbbVie Inc
12.1.1 AbbVie Inc Corporation Information
12.1.2 AbbVie Inc Business Overview
12.1.3 AbbVie Inc Interleukin 17A Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Inc Interleukin 17A Products Offered
12.1.5 AbbVie Inc Recent Development
12.2 Abeome Corporation
12.2.1 Abeome Corporation Corporation Information
12.2.2 Abeome Corporation Business Overview
12.2.3 Abeome Corporation Interleukin 17A Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abeome Corporation Interleukin 17A Products Offered
12.2.5 Abeome Corporation Recent Development
12.3 Affibody AB
12.3.1 Affibody AB Corporation Information
12.3.2 Affibody AB Business Overview
12.3.3 Affibody AB Interleukin 17A Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Affibody AB Interleukin 17A Products Offered
12.3.5 Affibody AB Recent Development
12.4 Cell Medica Limited
12.4.1 Cell Medica Limited Corporation Information
12.4.2 Cell Medica Limited Business Overview
12.4.3 Cell Medica Limited Interleukin 17A Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cell Medica Limited Interleukin 17A Products Offered
12.4.5 Cell Medica Limited Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Corporation Information
12.5.2 Eli Lilly and Company Business Overview
12.5.3 Eli Lilly and Company Interleukin 17A Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eli Lilly and Company Interleukin 17A Products Offered
12.5.5 Eli Lilly and Company Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Business Overview
12.6.3 Johnson & Johnson Interleukin 17A Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Interleukin 17A Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Merck KGaA
12.7.1 Merck KGaA Corporation Information
12.7.2 Merck KGaA Business Overview
12.7.3 Merck KGaA Interleukin 17A Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck KGaA Interleukin 17A Products Offered
12.7.5 Merck KGaA Recent Development
12.8 Novartis AG
12.8.1 Novartis AG Corporation Information
12.8.2 Novartis AG Business Overview
12.8.3 Novartis AG Interleukin 17A Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novartis AG Interleukin 17A Products Offered
12.8.5 Novartis AG Recent Development
12.9 Orega Biotech SAS
12.9.1 Orega Biotech SAS Corporation Information
12.9.2 Orega Biotech SAS Business Overview
12.9.3 Orega Biotech SAS Interleukin 17A Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Orega Biotech SAS Interleukin 17A Products Offered
12.9.5 Orega Biotech SAS Recent Development
13 Interleukin 17A Manufacturing Cost Analysis
13.1 Interleukin 17A Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Interleukin 17A
13.4 Interleukin 17A Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Interleukin 17A Distributors List
14.3 Interleukin 17A Customers
15 Market Dynamics
15.1 Interleukin 17A Market Trends
15.2 Interleukin 17A Opportunities and Drivers
15.3 Interleukin 17A Market Challenges
15.4 Interleukin 17A Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Interleukin 17A Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Interleukin 17A Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Interleukin 17A Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Interleukin 17A Sales (K Pcs) by Region (2015-2020)
Table 5. Global Interleukin 17A Sales Market Share by Region (2015-2020)
Table 6. Global Interleukin 17A Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Interleukin 17A Revenue Share by Region (2015-2020)
Table 8. Global Interleukin 17A Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Interleukin 17A Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Interleukin 17A Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Interleukin 17A Revenue Share Forecast by Region (2021-2026)
Table 12. Global Interleukin 17A (K Pcs) of Key Companies (2015-2020)
Table 13. Global Interleukin 17A Sales Share by Company (2015-2020)
Table 14. Global Interleukin 17A Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Interleukin 17A Revenue Share by Company (2015-2020)
Table 16. Global Interleukin 17A by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interleukin 17A as of 2019)
Table 17. Global Interleukin 17A Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Interleukin 17A Manufacturing Sites and Area Served
Table 19. Manufacturers Interleukin 17A Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Interleukin 17A Players
Table 22. Global Interleukin 17A Sales (K Pcs) by Type (2015-2020)
Table 23. Global Interleukin 17A Sales Share by Type (2015-2020)
Table 24. Global Interleukin 17A Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Interleukin 17A Price (K Pcs) by Type (2015-2020)
Table 26. Global Interleukin 17A Sales Share by Type (2021-2026)
Table 27. Global Interleukin 17A Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Interleukin 17A Revenue Share by Type (2021-2026)
Table 29. Global Interleukin 17A Price (K Pcs) by Type (2021-2026)
Table 30. Global Interleukin 17A Sales (K Pcs) by Application (2015-2020)
Table 31. Global Interleukin 17A Sales Share by Application (2015-2020)
Table 32. Global Interleukin 17A Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Interleukin 17A Price (K Pcs) by Application (2015-2020)
Table 34. Global Interleukin 17A Sales (K Pcs) by Application (2021-2026)
Table 35. Global Interleukin 17A Sales Share by Application (2021-2026)
Table 36. Global Interleukin 17A Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Interleukin 17A Revenue Share by Application (2021-2026)
Table 38. Global Interleukin 17A Price (K Pcs) by Application (2021-2026)
Table 39. United States Interleukin 17A Sales (K Pcs) by Company (2015-2020)
Table 40. United States Interleukin 17A Sales Market Share by Company (2015-2020)
Table 41. United States Interleukin 17A Sales (K Pcs) by Type (2015-2020)
Table 42. United States Interleukin 17A Sales Market Share by Type (2015-2020)
Table 43. United States Interleukin 17A Sales (K Pcs) by Application (2015-2020)
Table 44. United States Interleukin 17A Sales Market Share by Application (2015-2020)
Table 45. Europe Interleukin 17A Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Interleukin 17A Sales Market Share by Company (2015-2020)
Table 47. Europe Interleukin 17A Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Interleukin 17A Sales Market Share by Type (2015-2020)
Table 49. Europe Interleukin 17A Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Interleukin 17A Sales Market Share by Type (2015-2020)
Table 51. China Interleukin 17A Sales (K Pcs) by Company (2015-2020)
Table 52. China Interleukin 17A Sales Market Share by Company (2015-2020)
Table 53. China Interleukin 17A Sales (K Pcs) by Type (2015-2020)
Table 54. China Interleukin 17A Sales Market Share by Type (2015-2020)
Table 55. China Interleukin 17A Sales (K Pcs) by Application (2015-2020)
Table 56. China Interleukin 17A Sales Market Share by Application (2015-2020)
Table 57. Japan Interleukin 17A Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Interleukin 17A Sales Market Share by Company (2015-2020)
Table 59. Japan Interleukin 17A Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Interleukin 17A Sales Market Share by Type (2015-2020)
Table 61. Japan Interleukin 17A Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Interleukin 17A Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Interleukin 17A Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Interleukin 17A Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Interleukin 17A Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Interleukin 17A Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Interleukin 17A Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Interleukin 17A Sales Market Share by Application (2015-2020)
Table 69. India Interleukin 17A Sales (K Pcs) by Company (2015-2020)
Table 70. India Interleukin 17A Sales Market Share by Company (2015-2020)
Table 71. India Interleukin 17A Sales (K Pcs) by Type (2015-2020)
Table 72. India Interleukin 17A Sales Market Share by Type (2015-2020)
Table 73. India Interleukin 17A Sales (K Pcs) by Application (2015-2020)
Table 74. India Interleukin 17A Sales Market Share by Application (2015-2020)
Table 75. AbbVie Inc Corporation Information
Table 76. AbbVie Inc Description and Business Overview
Table 77. AbbVie Inc Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. AbbVie Inc Interleukin 17A Product
Table 79. AbbVie Inc Recent Development
Table 80. Abeome Corporation Corporation Information
Table 81. Abeome Corporation Description and Business Overview
Table 82. Abeome Corporation Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Abeome Corporation Interleukin 17A Product
Table 84. Abeome Corporation Recent Development
Table 85. Affibody AB Corporation Information
Table 86. Affibody AB Description and Business Overview
Table 87. Affibody AB Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Affibody AB Interleukin 17A Product
Table 89. Affibody AB Recent Development
Table 90. Cell Medica Limited Corporation Information
Table 91. Cell Medica Limited Description and Business Overview
Table 92. Cell Medica Limited Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Cell Medica Limited Interleukin 17A Product
Table 94. Cell Medica Limited Recent Development
Table 95. Eli Lilly and Company Corporation Information
Table 96. Eli Lilly and Company Description and Business Overview
Table 97. Eli Lilly and Company Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Eli Lilly and Company Interleukin 17A Product
Table 99. Eli Lilly and Company Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Interleukin 17A Product
Table 104. Johnson & Johnson Recent Development
Table 105. Merck KGaA Corporation Information
Table 106. Merck KGaA Description and Business Overview
Table 107. Merck KGaA Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Merck KGaA Interleukin 17A Product
Table 109. Merck KGaA Recent Development
Table 110. Novartis AG Corporation Information
Table 111. Novartis AG Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Novartis AG Description and Business Overview
Table 113. Novartis AG Interleukin 17A Product
Table 114. Novartis AG Recent Development
Table 115. Orega Biotech SAS Corporation Information
Table 116. Orega Biotech SAS Interleukin 17A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Orega Biotech SAS Description and Business Overview
Table 118. Orega Biotech SAS Interleukin 17A Product
Table 119. Orega Biotech SAS Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Interleukin 17A Distributors List
Table 123. Interleukin 17A Customers List
Table 124. Interleukin 17A Market Key Trends
Table 125. Interleukin 17A Key Opportunities and Drivers
Table 126. Interleukin 17A Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Interleukin 17A Product Picture
Figure 2. Global Interleukin 17A Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Interleukin 17A Market Share by Application in 2020 & 2026
Figure 6. Chronic Pain Examples
Figure 7. Liver Cancer Examples
Figure 8. Kidney Cancer Examples
Figure 9. Others Examples
Figure 10. Global Interleukin 17A Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Interleukin 17A Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Interleukin 17A Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Interleukin 17A Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Interleukin 17A Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Interleukin 17A Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Interleukin 17A Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Interleukin 17A Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Interleukin 17A Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Interleukin 17A Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Interleukin 17A Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Interleukin 17A Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Interleukin 17A Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Interleukin 17A Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Interleukin 17A Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Interleukin 17A Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Interleukin 17A Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Interleukin 17A Players Market Share by Revenue in Interleukin 17A 2015 & 2019
Figure 28. Interleukin 17A Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Interleukin 17A Revenue Share by Type (2015-2020)
Figure 30. Global Interleukin 17A Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Interleukin 17A Revenue Share by Application (2015-2020)
Figure 32. Global Interleukin 17A Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Interleukin 17A Sales Market Share by Type in 2019
Figure 34. United States Interleukin 17A Sales Market Share by Type in 2019
Figure 35. Europe Interleukin 17A Sales Market Share by Company in 2019
Figure 36. Europe Interleukin 17A Sales Market Share by Type in 2019
Figure 37. Europe Interleukin 17A Sales Market Share by Application in 2019
Figure 38. China Interleukin 17A Sales Market Share by Company in 2019
Figure 39. China Interleukin 17A Sales Market Share by Type in 2019
Figure 40. China Interleukin 17A Sales Market Share by Application in 2019
Figure 41. Japan Interleukin 17A Sales Market Share by Company in 2019
Figure 42. Japan Interleukin 17A Sales Market Share by Type in 2019
Figure 43. Japan Interleukin 17A Sales Market Share by Application in 2019
Figure 44. Southeast Asia Interleukin 17A Sales Market Share by Company in 2019
Figure 45. Southeast Asia Interleukin 17A Sales Market Share by Type in 2019
Figure 46. Southeast Asia Interleukin 17A Sales Market Share by Application in 2019
Figure 47. India Interleukin 17A Sales Market Share by Company in 2019
Figure 48. India Interleukin 17A Sales Market Share by Type in 2019
Figure 49. India Interleukin 17A Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Interleukin 17A
Figure 52. Manufacturing Process Analysis of Interleukin 17A
Figure 53. Interleukin 17A Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
慢性腎臓病治療薬の世界市場レポート2020 Market Analysis and Insights: Global Chronic Kidney Disease Drugs Market The global Chronic Kidney Disease Drugs market size is projected to reach US$ 12450 million by 2026, from US$ 11220 million in 2020, at a CAGR of 1.8% during 2021-2026. Global Chronic Kidney Disease Drugs Scope and Market Size …- GMPサイトカインの世界市場レポート2020 Cytokines are a large group of small signaling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. North Ameri…
- がん画像システムの世界市場レポート2020 Market Analysis and Insights: Global Cancer Imaging System Market The global Cancer Imaging System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Cancer Imaging System Scope and Market Size The global Cancer Imaging Sy…
- がん治療用放射性ステントの世界市場レポート2020 Radioactive stent, the self-expanding stent with radioactivity particles is regards as very useful in the treatment of medium and advanced esophageal cancer. Jiangsu Province is the largest suppling place as the top 3 manufacturers are located therem Micro-Tech, Changzhou Zhiye and Changzhou Garson.…
- がん診断装置の世界市場レポート2020 Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical compan…